Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
11/2011
11/01/2011CA2434526C Methods of administering epothilone analogs for the treatment of cancer
11/01/2011CA2404938C Production of polyketides
10/2011
10/27/2011WO2011133795A2 Beta-carbolines as inhibitors of haspin and dyrk kinases
10/27/2011WO2011133659A2 Inhibitors of hif and angiogenesis
10/27/2011WO2011132866A1 Novel compounds for organic electronic material and organic electroluminescent device using the same
10/27/2011WO2011132865A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/27/2011WO2011132712A1 Novel hydroxamic acid derivative
10/27/2011WO2011131709A1 Furopyridine compounds and uses thereof
10/27/2011WO2011087713A3 Substituted hexahydrochromeno [3, 4 - b] pyrroles with affinity for the serotonin receptor (5-ht) family
10/27/2011US20110263597 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
10/27/2011US20110263588 Tricyclic compounds as glutamate receptor modulators
10/27/2011US20110263564 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
10/27/2011US20110263519 Regulators of the hedgehog pathway, compositions and uses related thereto
10/27/2011US20110263494 Nonsteroidal compounds useful as modulators of glucocorticoid receptor ap-1 and/or nf-kappab acitivity and use thereof
10/27/2011US20110263424 Oxaspirocyclic Spiro-Substituted Tetramic Acid and Tetronic Acid Derivatives
10/26/2011EP2379562A1 Bicyclic pyranone derivatives as nicotinic acid receptor agonists
10/26/2011EP2379559A2 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
10/26/2011EP2379515A2 Benzoxazole-based fluorescent metal ion indicators
10/26/2011EP2378877A1 Imidazolinone derivatives as cgrp receptor antagonists
10/26/2011EP2142538B1 Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists
10/25/2011US8044203 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups
10/20/2011WO2011130741A1 Compounds for treating neurodegenerative diseases
10/20/2011WO2011079230A3 Heterocyclic compounds as janus kinase inhibitors
10/20/2011WO2011060049A3 Spiro-oxindole mdm2 antagonists
10/20/2011US20110257215 Novel co-crystal of tiotropium bromide
10/19/2011EP2377398A1 16-ketoaspergillimide and pest exterminating agent comprising the same as active ingredient
10/19/2011EP2376498A1 Novel c-1analogs of pancratistatin and 7-deoxypancratistatin and processes for their preparation
10/19/2011EP2376497A1 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
10/19/2011EP2376495A2 Compositions of protein receptor tyrosine kinase inhibitors
10/19/2011EP2376080A1 Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates
10/19/2011EP1648870B1 Sulfonic acid derivatives of polycyclic dyes used for analytical applications
10/19/2011CN102224242A Novel gene cluster
10/19/2011CN102224156A Protease inhibitors
10/19/2011CN102224155A Protease inhibitors
10/19/2011CN102219789A Chromone acylhydrazone derivative of rhodamine B, and preparation method and application thereof
10/19/2011CN102219772A Cortex pseudolaricis acid complex with bioactivity and preparation method thereof
10/19/2011CN101384577B Novel coumarin derivative having antitumor activity
10/18/2011US8039641 Tetrahydrofuro[3,2-b] pyrrol-3-one intermediates
10/18/2011US8039626 Method of manufacturing of 7-ethyl-10-hydroxycamptothecin
10/18/2011US8039624 Vasopressin receptor antagonist; antidepressants; anxiolytic agents; dysmemorrhea; hypotensive agents;obsessive complusive disorder; cirrhosis; nephrotic syndrome
10/18/2011US8039488 Methods and compositions for inhibition of angiogenesis
10/18/2011US8039486 Viricides, immunomodulators or HIV entry inhibitors; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus; AIDS
10/18/2011US8039471 Aza spiro alkane derivatives as inhibitors of metalloproteases
10/18/2011US8039014 3′-alkoxyspirocyclopentyl-substituted tetramic and tetronic acids
10/18/2011CA2398018C Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/13/2011WO2011126225A1 Novel compounds for organic electronic material and organic electroluminescent device using the same
10/13/2011WO2011125930A1 Prophylactic or therapeutic agent for inflammatory bowel diseases or autoimmune peripheral neuropathy
10/13/2011WO2011125020A1 Substituted carbazole derivatives and use thereof in organic electronics
10/13/2011US20110251396 Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
10/13/2011US20110251225 Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
10/13/2011US20110251224 Spiro-oxindole compounds and their uses as therapeutic agents
10/13/2011US20110251216 Compositions and methods for inhibiting ezh2
10/13/2011US20110250656 Production of monascus-like azaphilone pigment
10/13/2011US20110250149 Tiotropium Bromide Having a Low Degree of Crystallinity
10/13/2011US20110250145 Bioluminescence imaging of myeloperoxidase activity in vivo, methods, compositions and apparatuses therefor
10/12/2011EP2374799A1 Process for the preparation of 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-carboxylates
10/12/2011EP2374796A1 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorders
10/12/2011EP2374795A1 Sulphonic acid derivatives of polycyclic dyes used for analytical applications
10/12/2011EP2373660A2 3,6-disubstituted xanthylium salts as medicaments
10/12/2011EP2373659A1 Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
10/12/2011EP1761522B1 Compounds and methods for treating dyslipidemia
10/12/2011CN102216308A [4- (1-amino-ethyl) -cyclohexyl] -methyl-amines as antibacterials
10/12/2011CN102216305A Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes
10/12/2011CN101851195B Quinoline compound and synthetic method and application thereof in synthesizing camptothecin alkaloid
10/12/2011CN101146808B Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors
10/11/2011US8034949 Pyrrolidine compound and a process for preparing the same
10/11/2011US8034940 Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
10/11/2011US8034938 Imidazo[4,5-c]quinolines, 6,7,8,9-tetrahydroimidazo[4,5-c]quinolines, imidazo[4,5-c]naphthyridines, and 6,7,8,9-tetrahydroimidazo[4,5-c]naphthyridines) with a CH( R1) group in the fused ring at 1-position of imidazo ring; modulate immune response, by induction of cytokine biosynthesis or other mechanism
10/11/2011US8034937 e.g.1'-[(6-chloro-1H-indol-3-yl)carbonyl]-7H-spiro[furo[3,4-b]pyridine-5,4'-piperidine]; vasopressin V1a receptor antagonist; antidepressant and anxiolytic agent; dysmenorrhea, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome
10/11/2011US8034832 Gyrase inhibitors and uses thereof
10/11/2011US8034818 Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates
10/11/2011US8034806 Bicyclic mGluR5 positive allosteric modulators and methods of making and using same
10/11/2011CA2520852C 7-([1,4]dioxan-2-yl)-benzothiazole derivative as adenosine receptor ligands
10/06/2011WO2010083359A3 New materials with aza-dibenzothiophene or aza-dibenzofuran core for pholed
10/06/2011US20110245505 Process for Manufacturing 5-Formyl-Pyridine-2,3-Dicarboxylic Acid Esters
10/06/2011US20110245504 SYNTHESIS OF 9-(ARYLALKYL)-1,2,3,4-TETRAHYDRO-y-CARBOLINE AND ANALOGUES AND INTERMEDIATES
10/06/2011US20110245353 Sweet flavor modifier
10/06/2011US20110245240 Cgrp receptor antagonists
10/06/2011US20110245156 Novel antiviral compounds, compositions, and methods of use
10/06/2011US20110244486 Methods and compositions for the diagnosis and treatment of diabetes
10/06/2011US20110243940 Bicyclic pyranone derivatives and methods of use thereof
10/05/2011EP2370444A1 [4- (1-amino-ethyl) -cyclohexyl]-methyl-amines as antibacterials
10/05/2011EP2370407A1 Carbazole and carboline kinase inhibitors
10/05/2011EP2370406A1 High penetration compositions and their applications
10/05/2011EP2240492B1 Process for the preparation of asenapine and intermediate products used in said process
10/05/2011CN1553913B Process for the direct preparation of pyrrolo [3,4-c]pyrroles
10/05/2011CN102209717A Compounds for the treatment of hepatitis c
10/05/2011CN102209714A Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
10/05/2011CN102209711A Compounds for the treatment of hepatitis c
10/05/2011CN102206223A Optical probe film and special-purposed organic dye for micro determination of copper ion content in water sample
10/05/2011CN102206222A 2-fatty-amino-substituted indole quinoline derivative and preparation method and application thereof in preparation of antitumor drugs
10/05/2011CN102206217A Heterocyclic compounds for treating or preventing diabetes mellitus as dipeptidyl peptidase inhibitor
10/05/2011CN102206180A Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
10/05/2011CN102206179A Bipyridine alkaloid compound and preparation method and use thereof
10/05/2011CN101450949B Chemical semi-synthetic process of 10-hydroxycamptothecin
10/05/2011CN101432288B Process for production of camptothecin derivative
10/05/2011CN101347467B Effective component of common camptotheca fruit and preparation as well as use thereof
10/04/2011US8030325 Biosynthetic gene cluster for the production of a complex polyketide
10/04/2011US8030321 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor
10/04/2011US8030096 Water-soluble rhodamine dyes conjugates
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 298